7 research outputs found
The role of GlcNAc-PI-de-N-acetylase gene by gene knockout through homologous recombination and its consequences on survival, growth and infectivity of Leishmania major in in vitro and in vivo conditions
At present, there are no efficacious vaccines or effective drugs against leishmaniasis; therefore new and
innovative control methods are urgently required. One way to achieve this important goal is through using
reverse genetic engineering to evaluate important enzymes, proteins and macromolecules. One of the
most important enzymes for Glycosylphosphatidylinositol (GPI) biosynthetic pathways is GlcNAc-PI-deN-acetylase (GPI12). The molecular constructs were cloned in Escherichia coli strain Top 10 and confirmed
by molecular methods and were transfected by electroporation into Leishmania major. We demonstrated
that two alleles of the GPI12 gene in L. major were successfully removed and enabling the generation of
a null mutant, which supports the idea that GPI12 is not an essential gene for the growth and survival of
Leishmania and the homozygous knockouts of Leishmania are able to survive. We were able to produce
a mutant parasite that caused no damaged to the host. Further investigations are essential to check the
safety profile in laboratory animal
مطالعه حذف ژن GLcNAc-PI-de-N-acetylase لیشمانیا ماژور به صورت homologous recombination در شرایط برون تنی و درون تنی
Study of the role of GLcNAc-PI-de-N-acetylase gene by gene knockout through homologous recombination & its consequences on survival , growth & infectivity of L. major in in vitro & in vivo condition
Designing and Cloning Molecular Constructs to Knock Out N-Acetylglucosamine Phosphatidylinositol De-N-Acetylase (GPI12) Gene in Leishmania major (MRHO/IR/75/ER)
Background: Leishmaniasis represents a major public health concern in tropical and sub-tropical countries. At present, there is no efficacious vaccine against the disease and new control methods are needed. One way to access this important goal is to knock out genes of specific macromolecules to evaluate the effect of deletion on the growth, multiplication, pathogenesis and immunity of the parasite. The aim of this study was to design and clone molecular constructs to knock out N-acetylglucosamine phosphatidylinositol de-N-acetylase (GPI12) gene in Leishmania major.
Methods: For designing and making molecular constructs, we used pLEXSY-neo2 and pLEXSY-hyg2 vectors. The molecular constructs were cloned in E. coli strain Top10. The molecular constructs were transfected by electroporation into L. major in two stages.
Results: The molecular constructs were confirmed by Colony PCR and sequencing. The recombinant strains were isolated by selective antibiotics, after which they were confirmed by PCR, Southern and Western blots.
Conclusion: Recombinant parasites were created and examined for subsequent study. With the use of molecular constructs, it was possible to remove and study gene GPI12 and to achieve a live recombinant Leishmania parasite that maintained the original form of the antigenic parasites. This achievement can be used as an experimental model for vaccine development studies. Further investigations are essential to check this model in a suitable host